nach oben

NeuroMolecular Medicine

Erschienen in:

24.06.2016 | Review Paper

Recommendations for Development of Botanical Polyphenols as “Natural Drugs” for Promotion of Resilience Against Stress-Induced Depression and Cognitive Impairment

verfasst von: Libby Ward, Giulio Maria Pasinetti

Erschienen in: NeuroMolecular Medicine | Ausgabe 3/2016

Einloggen, um Zugang zu erhalten

Abstract

Extensive evidence has demonstrated that psychological stress has detrimental effects on psychological health, cognitive function, and ultimately well-being. While stressful events are a significant cause of psychopathology, most individuals exposed to adversity maintain normal psychological functioning. The mechanisms underlying such resilience are poorly understood, and there is an urgent need to identify and target these mechanisms to promote resilience under stressful events. Botanicals have been used throughout history to treat various medical conditions; however, the development of botanical compounds into potential preventative and therapeutic agents in studies promoting brain health is hindered by the fact that most orally consumed botanicals are extensively metabolized during absorption and/or by post-absorptive xenobiotic metabolism. Therefore, the primary objective of this review article is to provide recommendations for developing natural compounds as novel therapeutic strategies to promote resilience in susceptible subjects. The development of botanical polyphenols to ultimately attenuate mood disorders and cognitive impairment will rely on understanding (1) the absorption and bioavailability of botanical polyphenols with emphasis on flavan-3-ols, (2) the characterization of tissue-specific accumulation of biologically available polyphenols and their mechanisms of action in the brain, and eventually (3) the characterization of biologically available polyphenol metabolites in mechanisms associated with the promotion of resilience against mood disorders and cognitive impairment in response to stress. We also summarize exciting new lines of investigation about the role of botanicals such as polyphenols in the promotion of cognitive and psychological resilience. This information will provide a strategical framework for the future development of botanicals as therapeutic agents to promote resilience, ultimately preventing and/or therapeutically treating cognitive impairment and psychological dysfunction.

Abd El Mohsen, M. M., Kuhnle, G., Rechner, A. R., Schroeter, H., Rose, S., Jenner, P., et al. (2002). Uptake and metabolism of epicatechin and its access to the brain after oral ingestion. Free Radical Biology and Medicine, 33, 1693–1702.CrossRefPubMed

Abd El-Mohsen, M., Bayele, H., Kuhnle, G., Gibson, G., Debnam, E., Kaila, S. S., et al. (2006). Distribution of [3H]trans-resveratrol in rat tissues following oral administration. British Journal of Nutrition, 96, 62–70.CrossRefPubMed

Aburn, G., Gott, M., & Hoare, K. (2016). What is resilience? An integrative review of the empirical literature. Journal of Advanced Nursing, 72, 980–1000.CrossRefPubMed

Association, A. P. (2013). Diagnostic and statistical manual of mental disorders. Arlington: American Psychiatric Publishing.

Aura, A. M., Mattila, I., Seppanen-Laakso, T., Miettinen, J., Oksman-Caldentey, K. M., & Oresic, M. (2008). Microbial metabolism of catechin stereoisomers by human faecal microbiota: comparison of targeted analysis and a non-targeted metabolomics method. Phytochemistry Letters, 1, 18–22.CrossRef

Aura, A. M., O’Leary, K. A., Williamson, G., Ojala, M., Bailey, M., Puupponen-Pimia, R., et al. (2002). Quercetin derivatives are deconjugated and converted to hydroxyphenylacetic acids but not methylated by human fecal flora in vitro. Journal of Agriculture and Food Chemistry, 50, 1725–1730.CrossRef

Bolca, S., Van de, W. T., & Possemiers, S. (2013). Gut metabotypes govern health effects of dietary polyphenols. Current Opinion in Biotechnology, 24, 220–225.CrossRefPubMed

Calani, L., Dall’Asta, M., Derlindati, E., Scazzina, F., Bruni, R., & Del, R. D. (2012). Colonic metabolism of polyphenols from coffee, green tea, and hazelnut skins. Journal of Clinical Gastroenterology, 46(Suppl), S95–S99.CrossRefPubMed

Chen, A. Y., & Chen, Y. C. (2013). A review of the dietary flavonoid, kaempferol on human health and cancer chemoprevention. Food Chemistry, 138, 2099–2107.CrossRefPubMed

Chen, H., Hayek, S., Rivera, G. J., Gillitt, N. D., Ibrahim, S. A., Jobin, C., et al. (2012). The microbiota is essential for the generation of black tea theaflavins-derived metabolites. PLoS One, 7, e51001.CrossRefPubMedPubMedCentral

Chen, T. Y., Kritchevsky, J., Hargett, K., Feller, K., Klobusnik, R., Song, B. J., et al. (2015). Plasma bioavailability and regional brain distribution of polyphenols from apple/grape seed and bilberry extracts in a young swine model. Molecular Nutrition and Food Research, 59, 2432–2447.CrossRefPubMed

Colten, H. R., Altevogt, B. M., & Institute of Medicine (and Committee on Sleep Medicine and Research). (2006). Sleep disorders and sleep deprivation an unmet public health problem. Institute of Medicine: Washington, DC.

Dowlati, Y., Herrmann, N., Swardfager, W., Liu, H., Sham, L., Reim, E. K., et al. (2010). A meta-analysis of cytokines in major depression. Biological Psychiatry, 67, 446–457.CrossRefPubMed

Farzaei, M. H., Bahramsoltani, R., Rahimi, R., Abbasabadi, F., & Abdollahi, M. (2016). A systematic review of plant-derived natural compounds for anxiety disorders. Current Topics in Medicinal Chemistry, 16, 1924–1942.CrossRefPubMed

Ferruzzi, M. G., Lobo, J. K., Janle, E. M., Cooper, B., Simon, J. E., Wu, Q. L., et al. (2009). Bioavailability of gallic acid and catechins from grape seed polyphenol extract is improved by repeated dosing in rats: implications for treatment in Alzheimer’s disease. Journal of Alzheimer’s Disease, 18, 113–124.PubMedPubMedCentral

Ford, D. E., & Kamerow, D. B. (1989). Epidemiologic study of sleep disturbances and psychiatric disorders. An opportunity for prevention? JAMA, 262, 1479–1484.CrossRefPubMed

Gasperotti, M., Passamonti, S., Tramer, F., Masuero, D., Guella, G., Mattivi, F., et al. (2015). Fate of microbial metabolites of dietary polyphenols in rats: Is the brain their target destination? ACS. Chemical Neuroscience, 6, 1341–1352.CrossRefPubMed

Gillin, J. C. (1998). Are sleep disturbances risk factors for anxiety, depressive and addictive disorders? Acta Psychiatrica Scandinavica. Supplementum, 393, 39–43.CrossRefPubMed

Goel, N., Rao, H., Durmer, J. S., & Dinges, D. F. (2009). Neurocognitive consequences of sleep deprivation. Seminars in Neurology, 29, 320–339.CrossRefPubMedPubMedCentral

Hirotsu, C., Tufik, S., Bergamaschi, C. T., Tenorio, N. M., Araujo, P., & Andersen, M. L. (2010). Sleep pattern in an experimental model of chronic kidney disease. American Journal of Physiology—Renal Physiology, 299, F1379–F1388.CrossRefPubMed

Ho, L., Ferruzzi, M. G., Janle, E. M., Wang, J., Gong, B., Chen, T. Y., et al. (2013). Identification of brain-targeted bioactive dietary quercetin-3-O-glucuronide as a novel intervention for Alzheimer’s disease. FASEB Journal, 27, 769–781.CrossRefPubMedPubMedCentral

Jiang, F., Chang, C. W., & Dusting, G. J. (2010). Cytoprotection by natural and synthetic polyphenols in the heart: novel mechanisms and perspectives. Current Pharmaceutical Design, 16, 4103–4112.CrossRefPubMed

Kamphuis, J., Meerlo, P., Koolhaas, J. M., & Lancel, M. (2012). Poor sleep as a potential causal factor in aggression and violence. Sleep Medicine, 13, 327–334.CrossRefPubMed

Kapur, V. K., Redline, S., Nieto, F. J., Young, T. B., Newman, A. B., & Henderson, J. A. (2002). The relationship between chronically disrupted sleep and healthcare use. Sleep, 25, 289–296.PubMed

Kiani, B. H., Suberu, J., & Mirza, B. (2016). Cellular engineering of Artemisia annua and Artemisia dubia with the rol ABC genes for enhanced production of potent anti-malarial drug artemisinin. Malar Journal, 15, 252.CrossRef

Kimhi, S. (2016). Levels of resilience: Associations among individual, community, and national resilience. Journal of Health Psychology, 21, 164–170.CrossRefPubMed

Kinrys, G., Coleman, E., & Rothstein, E. (2009). Natural remedies for anxiety disorders: potential use and clinical applications. Depression and Anxiety, 26, 259–265.CrossRef

Knutson, K. L., & Van, C. E. (2008). Associations between sleep loss and increased risk of obesity and diabetes. Annals of the New York Academy of Sciences, 1129, 287–304.CrossRefPubMedPubMedCentral

Kreutzer, J. S., Marwitz, J. H., Sima, A. P., Bergquist, T. F., Johnson-Greene, D., Felix, E. R., et al. (2016). Resilience following traumatic brain injury: A traumatic brain injury model systems study. Archives of Physical Medicine and Rehabilitation, 97, 708–713.CrossRefPubMed

Krikorian, R., Nash, T. A., Shidler, M. D., Shukitt-Hale, B., & Joseph, J. A. (2010). Concord grape juice supplementation improves memory function in older adults with mild cognitive impairment. British Journal of Nutrition, 103, 730–734.CrossRefPubMed

Krishnan, V., & Nestler, E. J. (2008). The molecular neurobiology of depression. Nature, 455, 894–902.CrossRefPubMedPubMedCentral

Lanquillon, S., Krieg, J. C., Bening-Abu-Shach, U., & Vedder, H. (2000). Cytokine production and treatment response in major depressive disorder. Neuropsychopharmacology, 22, 370–379.CrossRefPubMed

Maes, M., Bosmans, E., De, J. R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997). Increased serum IL-6 and IL-1 receptor antagonist concentrations in major depression and treatment resistant depression. Cytokine, 9, 853–858.CrossRefPubMed

Maes, M., Kubera, M., Obuchowiczwa, E., Goehler, L., & Brzeszcz, J. (2011). Depression’s multiple comorbidities explained by (neuro)inflammatory and oxidative and nitrosative stress pathways. Neuro Endocrinology Letters, 32, 7–24.PubMed

Maes, M., Van der, P. M., Stevens, W. J., Peeters, D., DeClerck, L. S., Bridts, C. H., et al. (1992). Leukocytosis, monocytosis and neutrophilia: hallmarks of severe depression. Journal of Psychiatric Research, 26, 125–134.CrossRefPubMed

Margalef, M., Pons, Z., Iglesias-Carres, L., Arola, L., Muguerza, B., & Arola-Arnal, A. (2016). Gender related similarities and differences in the body distribution of grape seed flavanols in rats. Molecular Nutrition and Food Research, 60, 760–772.CrossRefPubMed

Milbury, P. E., & Kalt, W. (2010). Xenobiotic metabolism and berry flavonoid transport across the blood-brain barrier. Journal of Agriculture and Food Chemistry, 58, 3950–3956.CrossRef

Miller, A. H., Maletic, V., & Raison, C. L. (2009). Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biological Psychiatry, 65, 732–741.CrossRefPubMedPubMedCentral

Monagas, M., Urpi-Sarda, M., Sanchez-Patan, F., Llorach, R., Garrido, I., Gomez-Cordoves, C., et al. (2010). Insights into the metabolism and microbial biotransformation of dietary flavan-3-ols and the bioactivity of their metabolites. Food and Function, 1, 233–253.CrossRefPubMed

Najafian, J., Mohamadifard, N., Siadat, Z. D., Sadri, G., & Rahmati, M. R. (2013). Association between sleep duration and diabetes mellitus: Isfahan Healthy Heart Program. Nigerian Journal of Clinical Practice, 16, 59–62.CrossRefPubMed

Newman, D. J., & Cragg, G. M. (2012). Natural products as sources of new drugs over the 30 years from 1981 to 2010. Journal of Natural Products, 75, 311–335.CrossRefPubMedPubMedCentral

Ozdal, T., Sela, D. A., Xiao, J., Boyacioglu, D., Chen, F., & Capanoglu, E. (2016). The reciprocal interactions between polyphenols and gut microbiota and effects on bioaccessibility. Nutrients, 8(2), 78.CrossRefPubMedCentral

Palagini, L., Bruno, R. M., Gemignani, A., Baglioni, C., Ghiadoni, L., & Riemann, D. (2013). Sleep loss and hypertension: a systematic review. Current Pharmaceutical Design, 19, 2409–2419.CrossRefPubMed

Pasinetti, G. M. (2012). Novel role of red wine-derived polyphenols in the prevention of Alzheimer’s disease dementia and brain pathology: Experimental approaches and clinical implications. Planta Medica, 78, 1614–1619.CrossRefPubMed

Prasain, J. K., Peng, N., Dai, Y., Moore, R., Arabshahi, A., Wilson, L., et al. (2009). Liquid chromatography tandem mass spectrometry identification of proanthocyanidins in rat plasma after oral administration of grape seed extract. Phytomedicine, 16, 233–243.CrossRefPubMed

Qureshi, N. A., & Al-Bedah, A. M. (2013). Mood disorders and complementary and alternative medicine: A literature review. Neuropsychiatric Disease and Treatment, 9, 639–658.CrossRefPubMedPubMedCentral

Rajaratnam, S. M. (2001). Legal issues in accidents caused by sleepiness. Journal of Human Ergology (Tokyo), 30, 107–111.

Rechner, A. R., Smith, M. A., Kuhnle, G., Gibson, G. R., Debnam, E. S., Srai, S. K., et al. (2004). Colonic metabolism of dietary polyphenols: Influence of structure on microbial fermentation products. Free Radical Biology and Medicine, 36, 212–225.CrossRefPubMed

Rush, A. J., Warden, D., Wisniewski, S. R., Fava, M., Trivedi, M. H., Gaynes, B. N., et al. (2009). STAR*D: Revising conventional wisdom. CNS Drugs, 23, 627–647.PubMed

Russo, S. J., Murrough, J. W., Han, M. H., Charney, D. S., & Nestler, E. J. (2012). Neurobiology of resilience. Nature Neuroscience, 15, 1475–1484.CrossRefPubMedPubMedCentral

Schmidt, B., Ribnicky, D. M., Poulev, A., Logendra, S., Cefalu, W. T., & Raskin, I. (2008). A natural history of botanical therapeutics. Metabolism, 57, S3–S9.CrossRefPubMedPubMedCentral

Selma, M. V., Espin, J. C., & Tomas-Barberan, F. A. (2009). Interaction between phenolics and gut microbiota: role in human health. Journal of Agriculture and Food Chemistry, 57, 6485–6501.CrossRef

Spencer, J. P. (2009). The impact of flavonoids on memory: physiological and molecular considerations. Chemical Society Reviews, 38, 1152–1161.CrossRefPubMed

Van Dongen, H. P., Maislin, G., Mullington, J. M., & Dinges, D. F. (2003). The cumulative cost of additional wakefulness: dose-response effects on neurobehavioral functions and sleep physiology from chronic sleep restriction and total sleep deprivation. Sleep, 26, 117–126.PubMed

Vijayan, V. K. (2012). Morbidities associated with obstructive sleep apnea. Expert Review of Respiratory Medicine, 6, 557–566.CrossRefPubMed

Wang, J., Ho, L., Zhao, W., Ono, K., Rosensweig, C., & Chen, L. (2008). Grape-derived polyphenolics prevent Abeta oligomerization and attenuate cognitive deterioration in a mouse model of Alzheimer’s disease. Journal of Neuroscience, 28, 6388–6392.CrossRefPubMedPubMedCentral

Wang, D., Xia, M., Yan, X., Li, D., Wang, L., Xu, Y., et al. (2012a). Gut microbiota metabolism of anthocyanin promotes reverse cholesterol transport in mice via repressing miRNA-10b. Circulation Research, 111, 967–981.CrossRefPubMed

Wang, J., Ferruzzi, M. G., Ho, L., Blount, J., Janle, E. M., Gong, B., et al. (2012b). Brain-targeted proanthocyanidin metabolites for Alzheimer’s disease treatment. Journal of Neuroscience, 32, 5144–5150.CrossRefPubMedPubMedCentral

Wang, D., Ho, L., Faith, J., Ono, K., Janle, E. M., Lachcik, P. J., et al. (2015). Role of intestinal microbiota in the generation of polyphenol-derived phenolic acid mediated attenuation of Alzheimer’s disease beta-amyloid oligomerization. Molecular Nutrition and Food Research, 59, 1025–1040.CrossRefPubMedPubMedCentral

Ward, N. C., Croft, K. D., Puddey, I. B., & Hodgson, J. M. (2004). Supplementation with grape seed polyphenols results in increased urinary excretion of 3-hydroxyphenylpropionic acid, an important metabolite of proanthocyanidins in humans. Journal of Agriculture and Food Chemistry, 52, 5545–5549.CrossRef

Wollen, K. A. (2010). Alzheimer’s disease: The pros and cons of pharmaceutical, nutritional, botanical, and stimulatory therapies, with a discussion of treatment strategies from the perspective of patients and practitioners. Alternative Medicine Review, 15, 223–244.PubMed

Titel: Recommendations for Development of Botanical Polyphenols as “Natural Drugs” for Promotion of Resilience Against Stress-Induced Depression and Cognitive Impairment
verfasst von: Libby Ward
Giulio Maria Pasinetti
Publikationsdatum: 24.06.2016
Verlag: Springer US
Erschienen in: NeuroMolecular Medicine / Ausgabe 3/2016
Print ISSN: 1535-1084
Elektronische ISSN: 1559-1174
DOI: https://doi.org/10.1007/s12017-016-8418-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

Psychotherapie Medizin aktuell

Fünf Jahren nach der Neugestaltung der Psychotherapie-Richtlinie wurden jetzt die Effekte der vorgenommenen Änderungen ausgewertet. Das Hauptziel der Novellierung war eine kürzere Wartezeit auf Therapieplätze. Dieses Ziel wurde nicht erreicht, es gab jedoch positive Auswirkungen auf andere Bereiche.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Recommendations for Development of Botanical Polyphenols as “Natural Drugs” for Promotion of Resilience Against Stress-Induced Depression and Cognitive Impairment

Abstract

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2016

Protective Effects of AGE and Its Components on Neuroinflammation and Neurodegeneration

Neuro-protective Mechanisms of Lycium barbarum

Clinacanthus nutans Extracts Modulate Epigenetic Link to Cytosolic Phospholipase A2 Expression in SH-SY5Y Cells and Primary Cortical Neurons

Effects of Long-Term Rice Bran Extract Supplementation on Survival, Cognition and Brain Mitochondrial Function in Aged NMRI Mice

Withania somnifera and Its Withanolides Attenuate Oxidative and Inflammatory Responses and Up-Regulate Antioxidant Responses in BV-2 Microglial Cells

Role of dietary phenols in mitigating microglia-mediated neuroinflammation

Leitlinien kompakt für die Neurologie

Neu im Fachgebiet Neurologie

Wartezeit nicht kürzer, aber Arbeit flexibler

„Restriktion auf vier Wochen Therapie bei Schlaflosigkeit ist absurd!“

Stuhltransfusion könnte Fortschreiten von Parkinson-Symptomen bremsen

Frühe Tranexamsäure-Therapie nützt wenig bei Hirnblutungen

Update Neurologie